Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Multiple sclerosis patients have a diminished serologic response to vitamin D supplementation compared to healthy controls
Authors
Keywords
-
Journal
Multiple Sclerosis Journal
Volume 22, Issue 6, Pages 753-760
Publisher
SAGE Publications
Online
2015-08-19
DOI
10.1177/1352458515600248
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Plasma Levels of 25-Hydroxyvitamin D3andIn VivoMarkers of Cytochrome P450 3A Activity in Swedes and Koreans: Effects of a Genetic Polymorphism and Oral Contraceptives
- (2014) Hanna Nylén et al. BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
- The Vitamin D to Ameliorate Multiple Sclerosis (VIDAMS) trial: Study design for a multicenter, randomized, double-blind controlled trial of vitamin D in multiple sclerosis
- (2014) Pavan Bhargava et al. Contemporary Clinical Trials
- Intestinal transport and metabolism of bile acids
- (2014) Paul A. Dawson et al. JOURNAL OF LIPID RESEARCH
- A Predictive Equation to Guide Vitamin D Replacement Dose in Patients
- (2014) G. Singh et al. Journal of the American Board of Family Medicine
- Predictors of serum 25(Oh)D increase following bimonthly supplementation with 100,000IU vitamin D in healthy, men aged 25–65 years
- (2013) Sigal Tepper et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Association between bile acid turnover and osteoporosis in postmenopausal women
- (2013) Ruth Hanly et al. NUCLEAR MEDICINE COMMUNICATIONS
- Increased Plasma Concentrations of Vitamin D Metabolites and Vitamin D Binding Protein in Women Using Hormonal Contraceptives: A Cross-Sectional Study
- (2013) Ulla Møller et al. Nutrients
- No evidence of association between mutant alleles of theCYP27B1gene and multiple sclerosis
- (2012) Maria Ban et al. ANNALS OF NEUROLOGY
- Interferon- and serum 25-hydroxyvitamin D interact to modulate relapse risk in MS
- (2012) N. Stewart et al. NEUROLOGY
- Efficacy of Vitamin D Supplementation in Multiple Sclerosis (EVIDIMS Trial): study protocol for a randomized controlled trial
- (2012) Jan Dörr et al. Trials
- Rare variants in the CYP27B1 gene are associated with multiple sclerosis
- (2011) Sreeram V. Ramagopalan et al. ANNALS OF NEUROLOGY
- Vitamin D3: a helpful immuno-modulator
- (2011) Michelino Di Rosa et al. IMMUNOLOGY
- Efficacy of vitamin D3 as add-on therapy in patients with relapsing–remitting multiple sclerosis receiving subcutaneous interferon beta-1a: A Phase II, multicenter, double-blind, randomized, placebo-controlled trial
- (2011) Joost Smolders et al. JOURNAL OF THE NEUROLOGICAL SCIENCES
- 1,25-Dihydroxyvitamin D3 Ameliorates Th17 Autoimmunity via Transcriptional Modulation of Interleukin-17A
- (2011) S. Joshi et al. MOLECULAR AND CELLULAR BIOLOGY
- Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
- (2011) Stephen Sawcer et al. NATURE
- Serum 25-hydroxyvitamin D status of vegetarians, partial vegetarians, and nonvegetarians: the Adventist Health Study-2
- (2009) Jacqueline Chan et al. AMERICAN JOURNAL OF CLINICAL NUTRITION
- Vitamin D status and effect of low-dose cholecalciferol and high-dose ergocalciferol supplementation in multiple sclerosis
- (2009) GS Hiremath et al. Multiple Sclerosis Journal
- Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20
- (2009) Melanie Bahlo et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started